Skip to main content

Published locations for ER+/HER2− advanced BC: Sapanisertib+fulvestrant offers modest benefit but additional toxicity

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ER+/HER2− advanced BC: Sapanisertib+fulvestrant offers modest benefit but additional toxicity

User login

  • Reset your password
  • /content/er/her2-advanced-bc-sapanisertibfulvestrant-offers-modest-benefit-additional-toxicity
  • /hematology-oncology/article/250863/breast-cancer/er/her2-advanced-bc-sapanisertibfulvestrant-offers
  • /breast-cancer-icymi/article/250863/breast-cancer/er/her2-advanced-bc-sapanisertibfulvestrant-offers